GLFD Guilford Pharmaceuticals (MM)

Guilford Pharmaceuticals to Host Webcast of Analyst Meeting on Tuesday, December 2, 2003 BALTIMORE, Dec. 1 /PRNewswire-FirstCall/ -- Guilford Pharmaceuticals announced today it will host an analyst meeting and webcast on Tuesday, December 2, 2003 at 12:30 p.m. Eastern Time (9:30 a.m. Pacific Time) to discuss the Company's product pipeline, AQUAVAN(R) Injection clinical program, and the acquisition of AGGRASTAT(R) Injection. Special guest speakers will include Dr. David J. Schneider, Associate Professor of Medicine, Director, Cardiology Unit, University of Vermont, and Dr. Lawrence Cohen, from New York Gastroenterologist Associates. Craig Smith, M.D., President and CEO of Guilford and other members of Guilford's clinical and marketing teams will host the event. To access the live webcast or subsequent archive please log onto Guilford's website at http://www.guilfordpharm.com/ at least 15 minutes prior to the start of the event to allow for any necessary downloads. About Guilford Guilford Pharmaceuticals Inc. is a fully integrated pharmaceutical company engaged in the research, development and commercialization of products that target the hospital market. Presently, Guilford markets two commercial products, GLIADEL(R) Wafer and AGGRASTAT(R) Injection. Guilford's product pipeline includes a novel anesthetic, AQUAVAN(R) Injection, and drugs for treating Parkinson's disease and post-prostatectomy erectile dysfunction. Contact: Guilford Pharmaceuticals Inc. Stacey Jurchison 410.631.5022 Internet addresses: http://www.guilfordpharm.com/ DATASOURCE: Guilford Pharmaceuticals Inc. CONTACT: Stacey Jurchison, Guilford Pharmaceuticals Inc., +1-410-631-5022, Web site: http://www.guilfordpharm.com/ Company News On-Call: http://www.prnewswire.com/comp/112882.html

Copyright